These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11797463)

  • 1. [Treatment of leiomyomas with gonadoliberin agonists].
    Puzigaca Z; Prelevic G; Markovic A
    Srp Arh Celok Lek; 2001; 129(5-6):143-6. PubMed ID: 11797463
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of gonadotropin-releasing hormone agonists on uterine leiomyomas.
    Cramer SF
    Arch Pathol Lab Med; 1998 Dec; 122(12):1045-6. PubMed ID: 9870847
    [No Abstract]   [Full Text] [Related]  

  • 3. Fibroids (uterine myomatosis, leiomyomas).
    Lethaby A; Vollenhoven B
    Clin Evid; 2004 Dec; (12):2563-85. PubMed ID: 15865807
    [No Abstract]   [Full Text] [Related]  

  • 4. GnRH agonist therapy before myomectomy or hysterectomy.
    Gutmann JN; Corson SL
    J Minim Invasive Gynecol; 2005; 12(6):529-37; quiz 528, 538-9. PubMed ID: 16337584
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term effectiveness and safety of GnRH agonist plus raloxifene administration in women with uterine leiomyomas.
    Palomba S; Orio F; Russo T; Falbo A; Cascella T; Doldo P; Nappi C; Lombardi G; Mastrantonio P; Zullo F
    Hum Reprod; 2004 Jun; 19(6):1308-14. PubMed ID: 15117890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroids (uterine myomatosis, leiomyomas).
    Lethaby A; Vollenhoven B
    Clin Evid; 2005 Dec; (14):2264-82. PubMed ID: 16620489
    [No Abstract]   [Full Text] [Related]  

  • 7. Potential cost savings using GnRH agonists as preoperative therapy for uterine leiomyomas.
    Saltiel E
    Formulary; 1995 Sep; 30(9):532-4, 542. PubMed ID: 10161243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [GnRH analogues and myomas: somewhat for].
    Bats AS; Madelenat P
    Gynecol Obstet Fertil; 2005 Dec; 33(12):1023-7. PubMed ID: 16316773
    [No Abstract]   [Full Text] [Related]  

  • 9. [GnRH analogues and myomas: which strategy?].
    Cohen J
    Gynecol Obstet Fertil; 2006 May; 34(5):462. PubMed ID: 16630742
    [No Abstract]   [Full Text] [Related]  

  • 10. [Morphometric and histological evaluation of uterine leiomyomas treated with GnRH agonists or progestational agents].
    Resta L; Sanguedolce F; Orsini G; Laricchia L; Piscitelli D; Fiore MG
    Pathologica; 2004 Apr; 96(2):35-41. PubMed ID: 15449444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [GnRH analogues and myomas: which strategy?].
    Poncelet C
    Gynecol Obstet Fertil; 2005 Dec; 33(12):1018. PubMed ID: 16316770
    [No Abstract]   [Full Text] [Related]  

  • 12. [GnRH analogues and myomas: against but...].
    Fernandez H
    Gynecol Obstet Fertil; 2005 Dec; 33(12):1019-22. PubMed ID: 16314135
    [No Abstract]   [Full Text] [Related]  

  • 13. Pathological evaluation of uterine leiomyomas treated with gonadotropin-releasing hormone agonist (GnRH-a) therapy: role of mast cells and a possible mechanism of GnRH-a resistance in leiomyomas.
    Nakayama M; Mitsuhashi T; Shimizu Y; Ishihara O; Shimizu M
    Pathol Int; 2008 May; 58(5):268-74. PubMed ID: 18429824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphometric and electron-microscopic analyses of the effects of gonadotropin-releasing hormone agonists on uterine leiomyomas.
    Kalir T; Goldstein M; Dottino P; Brodman M; Gordon R; Deligdisch L; Wu H; Gil J
    Arch Pathol Lab Med; 1998 May; 122(5):442-6. PubMed ID: 9593346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leiomyoma pseudocapsule after pre-surgical treatment with gonadotropin-releasing hormone agonists: relationship between clinical features and immunohistochemical changes.
    De Falco M; Staibano S; Mascolo M; Mignogna C; Improda L; Ciociola F; Carbone IF; Di Lieto A
    Eur J Obstet Gynecol Reprod Biol; 2009 May; 144(1):44-7. PubMed ID: 19297072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity and GnRH action. Report of a case with contribution by peripherally derived estrogens.
    Hansen LM; Batzer FR; Corson SL; Bello S
    J Reprod Med; 1997 Apr; 42(4):247-50. PubMed ID: 9131500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A comparative efficacy study of the preoperative use of GnRH agonists in women with uterine fibromyomas].
    Nikolov A; Karag'ozov I
    Akush Ginekol (Sofiia); 1999; 38(4):38-42. PubMed ID: 10726353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adjuvant therapy during the administration of GnRH agonists].
    Nikolov A; Kolarov G
    Akush Ginekol (Sofiia); 2002; 41(2):36-40. PubMed ID: 12066551
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of gonadotropin-releasing hormone agonists on leiomyomas.
    Mesia AF; Popiolek D
    Arch Pathol Lab Med; 1999 Apr; 123(4):282-3. PubMed ID: 10320136
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment strategies for uterine leiomyoma: the role of hormonal modulation.
    Cook JD; Walker CL
    Semin Reprod Med; 2004 May; 22(2):105-11. PubMed ID: 15164305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.